Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,170,191
-$311,506 QoQ
Shares Held
48,596
-7.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,232
of 2,821 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arvest Bank Trust Division holds $45,815,739 across 8 Drug Manufacturers - General names. PFE ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
60,049 | $15,110,729 | |
| 2 | JNJ |
Johnson & Johnson
|
57,057 | $14,490,765 | |
| 3 | LLY |
ELI LILLY & Co
|
9,403 | $11,278,240 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,386 | $1,848,601 | |
| 5 | PFE |
Pfizer Inc
This page
|
48,596 | $1,170,191 | |
| 6 | NVS |
Novartis AG
|
5,844 | $915,871 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,969 | $747,273 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,011 | $254,069 |
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,170,191 | 48,596 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,481,697 | 52,767 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,355,929 | 54,455 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,409,731 | 55,327 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,374,868 | 56,719 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,860,310 | 73,414 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,646,983 | 476,705 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,040,037 | 485,143 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $15,202,228 | 353,458 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,872,429 | 354,250 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $13,025,771 | 359,530 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $13,430,459 | 364,859 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $12,597,262 | 343,250 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $11,682,381 | 357,259 | Shares | Sole | 2020-08-21 | |
| 2020-03-31 | $11,668,587 | 357,494 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||